2367.HK
Price:
$76.7
Market Cap:
$74.40B
Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.
Industry
Household & Personal Products
IPO Date
2022-11-04
Stock Exchange
HKSE
Ticker
2367.HK
According to Giant Biogene Holding Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 34.39. This represents a change of 324.58% compared to the average of 8.10 of the last 4 quarters.
The mean historical PE Ratio of Giant Biogene Holding Co., Ltd. over the last ten years is 28.14. The current 34.39 PE Ratio has changed 12.12% with respect to the historical average. Over the past ten years (40 quarters), 2367.HK's PE Ratio was at its highest in in the December 2019 quarter at 21.41. The PE Ratio was at its lowest in in the December 2024 quarter at 0.
Average
28.14
Median
26.27
Minimum
21.80
Maximum
42.83
Discovering the peaks and valleys of Giant Biogene Holding Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 12.90%
Maximum Annual PE Ratio = 42.83
Minimum Annual Increase = -37.07%
Minimum Annual PE Ratio = 21.80
Year | PE Ratio | Change |
---|---|---|
2024 | 22.75 | 4.38% |
2023 | 21.80 | -24.58% |
2022 | 28.90 | 12.90% |
2021 | 25.60 | -5.03% |
2020 | 26.95 | -37.07% |
The current PE Ratio of Giant Biogene Holding Co., Ltd. (2367.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
24.48
5-year avg
25.20
10-year avg
28.14
Giant Biogene Holding Co., Ltd.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Giant Biogene Holding Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Giant Biogene Holding Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Giant Biogene Holding Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Giant Biogene Holding Co., Ltd. (2367.HK)?
What is the highest PE Ratio for Giant Biogene Holding Co., Ltd. (2367.HK)?
What is the 3-year average PE Ratio for Giant Biogene Holding Co., Ltd. (2367.HK)?
What is the 5-year average PE Ratio for Giant Biogene Holding Co., Ltd. (2367.HK)?
How does the current PE Ratio for Giant Biogene Holding Co., Ltd. (2367.HK) compare to its historical average?